Log in to save to my catalogue

Development of ACE2 autoantibodies after SARS-CoV-2 infection

Development of ACE2 autoantibodies after SARS-CoV-2 infection

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2569042410

Development of ACE2 autoantibodies after SARS-CoV-2 infection

About this item

Full title

Development of ACE2 autoantibodies after SARS-CoV-2 infection

Publisher

United States: Public Library of Science

Journal title

PloS one, 2021-09, Vol.16 (9), p.e0257016

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Activation of the immune system is implicated in the Post-Acute Sequelae after SARS-CoV-2 infection (PASC) but the mechanisms remain unknown. Angiotensin-converting enzyme 2 (ACE2) cleaves angiotensin II (Ang II) resulting in decreased activation of the AT1 receptor and decreased immune system activation. We hypothesized that autoantibodies against...

Alternative Titles

Full title

Development of ACE2 autoantibodies after SARS-CoV-2 infection

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2569042410

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2569042410

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0257016

How to access this item